xCures Inc.

San Francisco, California 94105

1 studies enrolling now · 1 studies all time

What they study most

BRAF Gene Mutation, Bladder Cancer, Cholangiocarcinoma, Colorectal Cancer, ERK Mutation, Esophageal Cancer, Gastric Cancer, Glioblastoma, HRAS Gene Mutation, Head and Neck Cancer, Hepatocellular Carcinoma, KRAS Activating Mutation

Studies at this site

• Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies — Available (expanded access)